US FDA approves AbbVie’s drug for Parkinson’s disease

Regulatory Approvals — US FDA approves AbbVie's drug for Parkinson's disease  reuters.com

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 25, 2026.

By